News

Latest news

Hide mandatory notifications of trade

Bionor Pharma Presenting Q2 2013 Interim Report by Webcast Friday 23 August at 8.30 am CEST

Oslo 16.08.2013 - Bionor Pharma ASA (OSE:BIONOR) will announce its Q2 2013 interim report Friday 23 August 2013 at 8.30.

We are pleased to invite you to join in on our international webcast (and teleconference) for analysts, investors and other stakeholders at 08.30 CEST to discuss the progress and results with Bionor Pharma’s senior management.

Webcast
A live audio webcast of the call will be available together with the slide presentation at
http://www.media-server.com/m/p/gc39czci

Q&A session
During the webcast, questions can be written online. We will answer questions at end of the presentation.
Call numbers
For those without a computer available, use the following number: +44(0)20 3427 1919 (UK), +1 646 254 3367 (US), +47 2350 0486 (Norway), +45 32 71 16 58 (Denmark) or +46(0)8 5065 3937 (Sweden), and request to be connected to the Bionor Pharma’s teleconference (confirmation code 2989037). Please use a quiet room.

Schedule for the webcast /teleconference 23 August (CEST time)
08.25  -Log in to the webcast-link, and/or call the above number 
08.30  -Review of results by Bionor Pharma’s senior management
           -Questions and answers

One week replay
There will be a replay facility available for one week (from one hour following the teleconference). The number to dial is +44(0)20 3427 0598 (UK), +1 347 366 9565 (US), +47 2100 0498 (Norway), +45 32 71 09 13 (Denmark) or +46(0)8 5051 3897 (Sweden), access code for all numbers is 2989037#.

Information about Bionor Pharma is available at www.bionorpharma.com

Bionor Pharma ASA
Hilde Aalling Syvertsen
-Director Communications & Corporate Affairs 
Tel +47 23 01 09 60